Federal contracts

Department of Defense added $945.1M to a contract with GSK

Award

Amount: $945,107,496
Agency: Department of Defense
Sub-agency: Department of the Army
Recipient: Glaxosmithkline
Parent: Glaxosmithkline
Stock: GSK
Stock link: Subsidiary known by name
Signed: 22/01/10
Published: 22/04/20
Performed in: NC-4
Type: Definitive contract
Modification number: P00001
Industry: Pharmaceutical preparation manufacturing
Product category: Medical and dental equipment and supplies

The amount this modification obligated.

What it buys

Sotrovimab

Members who traded GSK within 30 days

No member traded this stock within 30 days of the award.

Other federal contracts of GSK

			Performed in	Description
09/25	Department of Health and Human Services	$18.2MModification	NC-4	Department of Health and Human Services · Medical and dental equipment and supplies contract modification
25/09/26	Department of Health and Human Services	$27.3M	NC-4	Relenza (zanamivir) Rotadisk, 5MG
24/06/17	Department of Health and Human Services	$11.5M	NC-4	Storage and stability of AS03 adjuvant for the COVID-19 federal response
24/05/10	Department of Health and Human Services	$18.2M	NC-4	H5 pandemic readiness medical countermeasures
24/02/27	Department of Health and Human Services	$15.4M	NC-4	Fill and finish of AS03 adjuvant multi-dose vials for the COVID-19 response

All federal contracts of GSK